Overview

The PSYCKES team has developed an array of resources to support clinicians in providing their clients with the most effective treatment services while minimizing the risk of adverse effects. Available resources include information about the PSYCKES quality concerns, tools for clinical practice, and help with using the PSYCKES application.

News

• Scientific Summary #15. (62kb) A 2011 randomized controlled trial published in the American Journal of Psychiatry evaluated the benefits and risks of staying on antipsychotic polypharmacy ("stay") vs. switching to monotherapy ("switch"). The majority of the "switch" group was able to successfully transition to monotherapy without significant differences in symptom control compared to the "stay" group. The "switch" group also showed improved body mass index (BMI).

Calendar

Date	Time	Title
Tuesday, June 11, 2013	1 p.m. to 2 p.m.	Using PSYCKES for Clinicians June 11
Wednesday, July 17, 2013	11 a.m. to noon	Using PSYCKES for Clinicians July 17

Home | About OMH | News | Data & Reports | Publications | Resources | Employment | A-Z Site Map

Privacy Policy | Accessibility | Disclaimer | Contact OMH | Web Administrator

Last Modified: 11/8/2012

Security statement: Users shall not interrupt or disrupt the operation of this site nor restrict or inhibit any user's ability to access the site. Unauthorized attempts to upload information to the site or change information on the site or to interrupt or disrupt operation of the site are strictly prohibited and may subject the perpetrator to both civil and criminal penalties under Federal and/or State law.